Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: A short report

Helicobacter

Volumn 1, Issue 4, 1996, Pages 238-242

  Riff, Dennis S ^a   Kidd, S ^b   Rose, Pamela ^b   Haber, Marian ^c   Weissfeld, Alice ^d   Siepman, Nancy ^b  

^a Associated Gastroenterology   (United States)

^b TAP Holdings Limited   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d Microbiology Specialists Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; AMOXICILLIN; CLARITHROMYCIN; DRUG DERIVATIVE; ENZYME INHIBITOR; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG COMBINATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; STOMACH MUCOSA; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; TREATMENT OUTCOME;

EID: 0030309002     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1996.tb00045.x     Document Type: Article

References (27)

1. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-69.
2. Soil AH. Practice Parameter Committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease. JAMA 1996;275:622-9.
3. Labenz J, Ruhl GH, Stolte M, et al. Efficacy of one-week triple therapy to cure H. pylori infection [abstract 364]. Am J Gastroenterol 1994;89 (suppl):1376.
4. Buckley M, Xia HX, Hyde D, O'Morain C. A cost-effective European approach to H. pylori eradication [abstract 363]. Gut 1995;37(suppl 1):A91.
5. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori [abstract 317]. Am J Gastroenterol 1994;89(suppl): 1364.
6. Jaup BH, Norrby A. Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection [abstract 170]. Gut 1995; 37(suppl 1):A43.
7. Xia HX, Buckley M, Hyde D, et al. Effects of antibiotic-resistance in clarithromycin-combined triple therapy for Helicobacter pylori [abstract 218]. Gut 1995; 37(suppl 1):A55.
8. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-40.
9. Lamouliatte HC, Cayla R, Megraud F, et al. Amoxicillin-clarithromycin-omeprazole: The best therapy for Helicobacter pylori infection [abstract]? Acta Gastrenterol Belg 1993; 56(suppl): 140.
10. Moayyedi P, Tompkins DS, Axon ATR. Efficacy of ten days of clarithromycin, amoxycillin, and omeprazole in eradicating Helicobacter pylori infection [abstract 176]. Gut 1995;37(suppl 1):A44.
11. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, Langworthy H. One week low dose triple therapy for eradication of H. pylori: A multicentre randomised trial [abstract]. Gut 1996;38(suppl 1):A1.
12. Lind T, Veldhuyzen van Zanten SJO, Ungfe P, et al. The MACH l study: Optimal one-week treatment for H. pylori defined [abstract]? Gut 1995;37(suppl 1):A4.
13. Goddard AF, Logan RP, Tonge KA, et al. Eradication of H. pylori infection using clarithromycin, omeprazole, and amoxycillin for one week [abstract]. Gut 1995;37(suppl 1):A88.
14. Mones J, Ricart E, Sainz S. Helicobacter pylori eradication: Omeprazole, amoxicillin, and clarithromycin, 1 week vs. 2 weeks [abstract 2583]. In: Program and Abstracts of Digestive Diseases Week. San Francisco; 1996; A-646.
15. Lamouliatte H, Cayla R, Zerbib F, Talbi P, Megraud F. Triple therapy with PPI-amoxicillinclarithromycin for H. pylori eradication: The optimal regimen in 1996 [abstract 2586]. In: Program and Abstracts of Digestive Diseases Week. San Francisco; 1996; A-647.
16. Laine L, Estrada R, Trujillo M, Fukanaga K, Neil G. Randomized comparison of 7, 10, and 14 days of omeprazole, amoxicillin, and clarithromycin for treatment of H. pylori [abstract 4510]. In: Program and Abstracts of Digestive Diseases Week. San Francisco; 1996; A-1128.
17. Tytgat GNJ. Review article: Treatments that im-pact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Therap 1994;8:359-68.
18. Malanoski GJ, Eliopoulos GM, Ferraro MJ, Moellering RC Jr. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Eur J Clin Microbiol Infect Dis 1993;12:131-3.
19. Nagate T, Numata K, Hanada K, Kondo I. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics. J Clin Gastroenterol 1990; 12(suppl 1):S13J-8.
20. Logan RPH, Bardhan KD, Celestin LR, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: A randomized, double-blind, multicentre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Therap 1995; 9:417-23.
21. O'Morain C, Dettmer A, Rambow A, vonFritsch E, Fraser AG. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. Helicobacter. 1996;1:130-7.
22. Adamek RJ, Suerbaum S, Pfaffenbach B, Wegener M, Opferkuch W. Primary and acquired H. pylori resistance to clarithromycin, metronidazole, and amoxicillin [abstract 3926]. In: Program and Abstracts of Digestive Diseases Week. San Francisco: 1996; A-982.
23. Reddy R, Osato M, Gutierrez O, Kim JG, Graham DY. Metronidazole resistance is high in Korea and Columbia and appears to be rapidly increasing in the U.S. [abstract 3930]. In: Program and Abstracts of Digestive Diseases Week. San Francisco: 1996; A-983.
24. Tillinburg B, Labenz J, Siehoff S, et al. The situation of primary resistance of Helicobacter pylori to commonly used antibiotics in Germany [abstract P338]. In: Program and Abstracts of the 60th Annual Scientific Meeting of the American College of Gastroenterology. New York: 1995;287.
25. Olson C, Edmonds A. Primary susceptibility of H. pylori to clarithromycin compared to metronidazole in patients with duodenal ulcers associated with H. pylori infection [abstract P329]. In: Program and Abstracts of the 60th Annual Scientific Meeting of the American College of Gastroenterology. New York: 1995;381.
26. Lerang F, Moum B, Haug JB, et al. Highly effective twice a day triple therapies for Helicobacter infection and peptic ulcer disease-Metronidazole is of only minor importance [abstract 11]. In: Program and Abstracts of Digestive Diseases Week. San Francisco: 1996;A-3.
27. De Koster E, Cozzoli A. Jonas C, Ntounda R, Butzler JP, Deltenre M. Resistance of Helicobacter pylori to macrolides and imidazoles: A six years surveillance study [abstract 3932]. In: Program and Abstracts of Digestive Diseases Week. San Francisco: 1996;A-983.